BLOG

The world's largest summit dedicated to AI in medicine partners with the Novartis Foundation and NHSx

Posted by Intelligent Health on Jul 29, 2019 11:09:43 AM

CREATING A FUTURE WHERE AI WILL TRANSFORM HEALTH
THE WORLD'S LARGEST SUMMIT DEDICATED TO AI IN MEDICINE PARTNERS WITH THE NOVARTIS FOUNDATION AND NHSX TO REVOLUTIONISE AI IN MEDICINE IN LINE WITH THE UNITED NATIONS SUSTAINABLE DEVELOPMENT GOALS

 

Brought to you by InspiredMinds, the team behind World Summit AI (where the global AI agenda is set annually), Intelligent Health 2019 will host over 2,000 attendees, bring together 100 of the brightest brains in healthcare and tech to take centre stage, and aims to create a future where AI revolutionises healthcare.

 

You can have a sneak peek at the first 60 ground-breaking speakers confirmed so far, find out more about this inspiring event on our website and watch the 2018 aftermovie to get a taste of what's coming.

Read More

Topics: AI, Medicine, MedTech

From predictive to interpretable models

Posted by Volv Global on Jul 23, 2019 10:54:03 AM

By Christopher Rudolf, Founder and CEO at Volv Global

Quantifying Predictive Power of Features in Electronic Health Record Models – the Volv inTrigue way

When we work on complex prediction models with our inTrigue methodology, we are often asked to help clinicians and others to interpret these models by listing the patient features (attributes) which are used by the model to form its predictions.

Read More

Topics: AI, Medicine, MedTech

Speaker spotlight: General Electric’s GM of Women’s Health Ultrasound shares his biggest AI fear

Posted by GE Healthcare on Jul 16, 2019 2:40:54 PM

In 8 weeks’ time, Intelligent Health (11th-12th September), the world’s largest CPD accredited summit dedicated to AI in healthcare is descending on Basel, Switzerland.

 

To give you a taster of what's to come, meet Mr Roland Rott, Global GM of Women’s Health Ultrasound for GE Healthcare who joins our 2019 line up!


Read More

Topics: AI, Medicine, MedTech

Finding Patients for Rare Diseases: Accurate insight into rare diseases and targeted medicines enhanced by AI

Posted by Volv Global on Jul 9, 2019 3:13:38 PM

By Christopher Rudolf, Founder and CEO at Volv Global

 

The Case Study Problem

 

This case study derives from an ongoing Volv engagement, which started in July 2017. A pharmaceutical company approached Volv Global to develop a prediction model to identify additional patients suffering from the rare disease treatable by its specialist medicine.

 

Read More

Topics: AI, Medicine, MedTech

Refocusing Market Access for Difficult to diagnose diseases

Posted by Volv Global on Jun 26, 2019 12:09:51 PM

By Christopher Rudolf, Founder and CEO at Volv Global

 

Redefining your strategy using machine learning with Volv inTrigue

In this series of conversations with Volv leaders, I have been talking with Dr Mike Tremblay, Volv’s Chief Scientific and Medical Officer, about what differentiates the company in terms of value delivery into markets for our customers. I hope that this is of interest to those of you working with difficult to diagnose diseases and rare diseases in your daily activities.

 

Read More

Topics: AI, Medicine, MedTech